2019 +Dx Forum | April 3, 2019

The 5th annual +Dx Forum is quickly approaching.
Register now and join us in DC for an exciting day dedicated to the diagnostics laboratory industry.

register now

Five Unanswered Questions on the Medicare for All Act

On February 27, 2019, Representative Jayapal and more than 100 co-sponsors in the House of Representatives introduced the Medicare for All Act (HR 1384).

read more

McDermott+Consulting Expands Policy and Advocacy Team

We are pleased to announce that Rodney Whitlock and his policy team, Katie Weider and Emma Zimmerman have joined McDermott+Consulting.

meet our team

+Success

McDermottPlus persuaded the Centers for Medicare and Medicaid Services (CMS) to revise Medicare laboratory “Date of Service” regulations.

Codes currently eligible for exception to DOS rule

+Success

McDermottPlus assessed the policy pathway and operational feasibility to scale up group prenatal care, and designed alternative payment models to facilitate implementation.

States that already have the CenteringPregnancy model of Group Prenatal Care

+Success

On behalf of a coalition of leading global manufacturers of blood glucose monitoring systems, McDermottPlus successfully advanced legislation intended to improve market access and patient choice under the Medicare Competitive Bidding Program.

Reduction in Medicare payment amount for diabetes test strips since 2012

+Insights

Resource Centers

Dedicated resource libraries for clients and partner organizations.

Payment Innovation
Resource Center

A library of content about Medicare payment transformation initiatives. Includes original analysis, major regulations, agency guidance, program announcements and other primary source documents.

Diagnostics
Resource Center

A collection of primary source materials about laboratory diagnostics regulation and payment, including original analysis, Medicare rates, rulemakings, final determinations and other items of interest.

Prescription Drug
Resource Center

A collection of materials about prescription drug pricing initiatives and regulation from the Administration and Congress, original analysis, and other items of interest.

Insurance Coverage
Resource Center

A library of content about efforts to redesign health care insurance and coverage. Includes original analysis, major regulations, agency guidance, program announcements and other primary source documents.

Meet our Consultants

Albert Kusi-Appiah


Analyzes quantitative data and evaluates economic impact.

Deborah R. Godes


Advises clients on reimbursement and policy strategy.

Sheila Madhani


Advises clients on reimbursement policy strategy.

Paul Radensky, M.D.


A board certified internal medicine physician and lawyer who is recognized as a Medicare law and policy authority.

Eric Zimmerman


A recognized Medicare law and policy authority and registered lobbyist.

Christine Song


Analyzes quantitative data and evaluates the economic impact.

John Warren


A highly experienced Medicare veteran and former CMS director.

Mara McDermott


An accomplished health care executive with a deep understanding of federal health care law and policy.

Rachel Stauffer


A highly experienced government relations and legislative affairs strategist and advocate.

Rodney Whitlock, Ph.D.


An accomplished health care executive with more than two decades on the Hill specializing in rural health, the health care safety net and disability policy.

Katie Weider


An experienced government relations strategist who helps clients navigate the complex issues surrounding Medicare, Medicaid and the healthcare marketplace.

Emma Zimmerman


A government relations professional and registered lobbyist who supports clients on a range of health policy issues.

Upcoming Events

Apr 3

2019 +Dx Diagnostics Forum

Washington, DC

The +Dx Diagnostic Forum, now in its 5th year, is a must attend event for those in the laboratory diagnostics industry. Join us in DC for a day dedicated to the laboratory diagnostics industry!

Register Here

Nov 19

On-Demand Webinar | The IPI Model

Webinar

Watch the McDermott team discuss changes to the pharma ecosystem. Our team will breakdown CMS’s recently proposed international pricing index model for Medicare Part B drugs and biologicals.

read more
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope